BIO Statement on Confirmation of Ms. Seema Verma

March 13, 2017

BIO congratulates Ms. Seema Verma on her successful confirmation to lead the Centers for Medicare and Medicaid Services (CMS). We look forward to working with her and Secretary Price to advance patient-centric policies that promote affordable access to medicines and continued innovation.

Discover More

BIO Announces Dedicated Focus on Human Health and…

BIO to Transition Agricultural and Environmental Biotech Workstreams  Key Senior Hires Bolster Focus on Regulatory Affairs, Emerging Companies   and Economic Growth  Washington, DC, May 28, 2025 – The Biotechnology Innovation…

Learn more

John F. Crowley, President and CEO of the…

“Most favored nation is a deeply flawed proposal that would devastate our nation’s small- and mid-size biotech companies – the very companies that are the leading drivers of medical innovation in the United States and the cornerstone of America’s…

Learn more

BIO Statement on National Security Commission on…

WASHINGTON, DC, April 8, 2025 – Today, the National Security Commission on Emerging Biotechnology (NSCEB), a bipartisan legislative commission established by Congress, issued its much-anticipated report detailing how the United States risks…

Learn more